Observational studyAdvances in therapy2022

Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan.

Toru Nakazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.